Evidence map›Paper›PMID 40564955›Full record

ArticleInternational journal of molecular sciences2025

Clinical and Genetic Characteristics of Parkinson's Disease Patients with Substantia Nigra Hyperechogenicity.

Łukasz Milanowski, Piotr Szukało, Małgorzata Kowalska, Alicja Sikorska, Dorota Hoffman-Zacharska, Dariusz Koziorowski

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Łukasz MilanowskiDepartment of Neurology, Faculty of Health Science, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0003-4197-8518
Piotr SzukałoStudent Scientific Group, Department of Neurology, Faculty of Health Science, Medical University of Warsaw, 02-091 Warsaw, Poland.
Małgorzata KowalskaDepartment of Neurology, Faculty of Health Science, Medical University of Warsaw, 02-091 Warsaw, Poland.
Alicja SikorskaStudent Scientific Group, Department of Neurology, Faculty of Health Science, Medical University of Warsaw, 02-091 Warsaw, Poland.
Dorota Hoffman-ZacharskaDepartment of Medical Genetics, Institute of Mother and Child, 01-211 Warsaw, Poland.ORCID 0000-0001-7367-512X
Dariusz KoziorowskiDepartment of Neurology, Faculty of Health Science, Medical University of Warsaw, 02-091 Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperechogenicity of the substantia nigra (SN) is observed using transcranial ultrasonography in patients with Parkinson's Disease. In this study, we investigated whether monogenic forms of PD are more prevalent in these patients and clinically defined their characteristics. Eighty-eight PD patients were part of the analysis. All patients received clinical diagnoses from experienced movement disorder specialists. Each patient underwent transcranial ultrasonography and genetic testing for mutations in the

Indexed as

Parkinson DiseaseSubstantia NigraAdultAgedalpha-SynucleinFemaleHumansLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MaleMiddle AgedMutationProtein Deglycase DJ-1Protein KinasesPTEN-Induced Putative KinaseUbiquitin-Protein LigasesUltrasonography, Doppler, Transcranialalpha-SynucleinLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanparkin proteinProtein Deglycase DJ-1Protein KinasesPTEN-Induced Putative KinaseSNCA protein, humanUbiquitin-Protein Ligasesgeneticshyperechogenicity of substantia nigraParkinson’s Diseasetranscranial ultrasonography

Identifiers

PMID40564955
PMCPMC12193131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.